ACUITY INC. (DE) financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ACUITY INC. (DE) files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	3,505	3,680	3,673	3,326	3,461	4,006	3,952	3,841	4,346	4,642
Cost of revenue	2,024	2,195	2,193	1,924	1,986	2,333	2,239	2,059	2,267	2,291
Gross profit	1,481	1,485	1,480	1,402	1,475	1,673	1,713	1,782	2,079	2,351
Research and development	52	63.9	74.7	82	88.3	95.1	97.1	102	140	166
Selling, general and administrative	942	1,019	1,015	1,029	1,044	1,163	1,213	1,228	1,485	1,613
Operating income	528	461	463	354	428	510	473	553	564	714
Interest expense	34.1	35.5	36.4	26.4	24.2	27	27.9	25.3	42.5	35.9
Interest income	1.6	2	3.1	3.1	1	2.1	9	29.8	20.5	10.3
Other non-operating income	-2.4	-1.4	-4.7	-5.9	-31.4	-15.8	-26.7	-4.7	-63.7	-33
Pre-tax income	493	426	425	325	396	494	447	549	500	681
Income tax	171	76.3	94.5	76.4	89.9	110	101	126	104	149
Income from continuing operations	322	350	330	248	306	384	346	423
Net income	322	350	330	248	306	384	346	423	397	531
EBITDA	602	541	551	455	528	605	567	644	697	870
EPS, basic	7.46	8.54	8.32	6.29	8.44	11.23	10.88	13.68	12.85	17.49
EPS, diluted	7.43	8.52	8.29	6.27	8.38	11.08	10.76	13.44	12.53	17.05
Shares, basic (weighted)	43.1	40.9	39.7	39.5	36.3	34.2	31.8	30.9	30.9	30.4
Shares, diluted (weighted)	43.3	41	39.8	39.6	36.6	34.6	32.2	31.4	31.6	31.2
Dividend per share	0.52	0.52	0.52	0.52	0.52	0.52	0.52	0.58	0.66	0.77

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	311	129	461	561	491	223	398	846	423	636
Receivables	573	638	561	500	572	666	555	563	594	632
Inventory	329	412	341	320	399	486	369	388	527	450
Other current assets	32.6	32.3	79	58.6	82.5	91.2	73.5	75.1	108	140
Total current assets	1,246	1,211	1,442	1,440	1,544	1,466	1,395	1,872	1,652	1,859
Property, plant and equipment	288	287	277	271	269	277	298	304	343	357
Lease right-of-use assets				63.4	58	74.9	84.1	65.6	97.4	99.5
Goodwill	901	971	967	1,080	1,095	1,084	1,098	1,099	1,496	1,494
Intangible assets	449	499	466	606	573	529	481	441	1,099	1,002
Other non-current assets	13.2	18.8	17.7	29.5	33.9	48	49.5	32.1	45.2	50.1
Total assets	2,900	2,989	3,172	3,492	3,575	3,480	3,409	3,815	4,755	4,874
Accounts payable	395	451	339	327	392	398	286	352	455	444
Accrued liabilities	41.8	67	73.2	89	95.3	88	103	110	110	148
Deferred revenue			4.7	5.4	7.7	11.4	14.1	17.4	21.4	25.7
Short-term debt	0.4	0.4	9.1	24.3	0	18	0	0	0	200
Total current liabilities	601	683	596	618	692	734	595	688	846	1,097
Long-term debt	357	356	348	377	494	495	496	496	897	497
Lease liabilities				56.8	46.7	67.4	75.5	58.1	84.3	83.2
Other non-current liabilities	6.2	8.2	5.2	2.5	9.3	0.8	129	130	139	134
Total liabilities	1,234	1,272	1,254	1,364	1,531	1,568	1,393	1,436	2,030	1,899
Total debt	357	357	357	401	494	495	496	496	897	697
Paid-in capital	881	906	930	964	996	1,036	1,067	1,116	1,165	1,192
Retained earnings	1,660	1,999	2,296	2,523	2,810	3,176	3,505	3,910	4,286	4,793
Treasury stock	-776	-1,074	-1,156	-1,227	-1,664	-2,175	-2,445	-2,533	-2,650	-2,939
Other comprehensive income	-99.7	-115	-151	-133	-98.2	-126	-113	-115	-76.5	-72.8
Shareholders' equity	1,666	1,717	1,919	2,128	2,045	1,912	2,015	2,379	2,725	2,974
Total equity	1,666	1,717	1,919	2,128	2,045	1,912	2,015	2,379	2,725	2,974
Total liabilities and equity	2,900	2,989	3,172	3,492	3,575	3,480	3,409	3,815	4,755	4,874

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	322	350	330	248	306	384	346	423	397	531
Depreciation and amortization	74.6	80.3	88.3	101	100	94.8	93.2	91.1	133	156
Stock-based compensation	32	32.3	29.2	38.2	32.5	37.4	42	46.6	45.1	49.5
Deferred income tax	-7.7	-38.2	9.3	-6.7	-2.7	0.6	-47.8	-33.6	-45	33.4
Change in receivables	2.7	-62.8	97.7	74.5	-68.7	-99.7	115	-8.7	26.3	-37.8
Change in inventory	-32.4	-74.4	70.8	38	-35.5	-83.3	115	-16.3	-34.2	74.7
Change in payables	-4.6	52.5	-112	-19.6	65.5	2.6	-111	66.2	64.4	-8.2
Cash from operations	337	352	495	505	409	316	578	619	601	826
Capital expenditures	-67.3	-43.6	-53	-54.9	-43.8	-56.5	-66.7	-64	-68.4	-77.7
Acquisitions	0	-163	-2.9	-303	-75.3	-12.9	-35.5	0	-1,189	0
Cash from investing	-48.8	-204	-53	-360	-118	-62.2	-90.7	-65.1	-1,281	-79.2
Debt issued	1		86.5	400	494	0	0	0	600	0
Debt repaid		-0.4	-86.9	-356	-401	0	0	0	-200	-400
Share buybacks	-358	-298	-81.6	-69.3	-435	-515	-267	-88.7	-119	-287
Dividends paid	-22.7	-21.4	-20.8	-20.8	-19.1	-18.1	-16.8	-18.2	-20.6	-23.8
Cash from financing	-392	-327	-108	-50.3	-363	-512	-313	-105	255	-537
Exchange rate effect	1.9	-2.8	-1.6	5	2.4	-9.8	0.2	-1.7	0.6	3.9
Net change in cash	-102	-182	332	99.7	-69.4	-268	175	448	-423	214
Free cash flow	269	308	442	450	365	260	511	555	533	748
Interest paid	33.6	36.7	35.6	29.8	22.2	26.1	27.9	24.4	40.5	35.1
Income taxes paid	174	127	92.9	64.6	86.4	109	147	156	152	108

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $332.59 on November 10, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	50.6%	Gross profit / revenue.
Operating margin	15.4%	Operating income / revenue.
EBITDA margin	18.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	14.7%	Pre-tax income / revenue.
Net margin	11.4%	Net income / revenue.
FCF margin	16.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	17.8%	Cash from operations / revenue.
Effective tax rate	21.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	18.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.0%	Net income / average total assets.
Return on invested capital (ROIC)	17.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	3.6%	Research and development expense / revenue.
SG&A / revenue	34.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.7%	Capital expenditures / revenue.
D&A / revenue	3.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	6.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	13.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	11.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	26.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	14.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	10.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	24.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	15.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	10.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	34.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	15.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	11.6%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	36.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	16.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	15.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	37.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	12.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	15.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	40.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	13.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	15.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	16.7%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	14.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	8.2%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	9.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	13.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	7.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	2.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	12.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-3.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.69x	Current assets / current liabilities.
Quick ratio	1.16x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.58x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.23x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	14.3%	Total debt / total assets.
Liabilities / assets	39.0%	Total liabilities / total assets.
Net debt	$61.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.07x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	19.9x	Operating income / interest expense.
Working capital	$762.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	51.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$479.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.96x	Revenue / average total assets.
Fixed asset turnover	13.3x	Revenue / average property, plant and equipment.
Inventory turnover	4.69x	Cost of revenue / average inventory.
Days inventory	78 days	365 x average inventory / cost of revenue.
Receivables turnover	7.57x	Revenue / average receivables.
Days sales outstanding	48 days	365 x average receivables / revenue.
Days payables	72 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	54 days	Days inventory + days sales outstanding - days payables.
FCF conversion	140.8%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	9.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$17.05	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$17.49	Net income per basic share, as reported (split-adjusted).
Revenue per share	$149.01	Revenue / diluted weighted shares.
FCF per share	$24.01	Free cash flow / diluted weighted shares.
Operating cash flow per share	$26.50	Cash from operations / diluted weighted shares.
Book value per share	$95.48	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$15.39	Tangible book value / shares outstanding.
Cash per share	$20.43	(Cash + short-term investments) / shares outstanding.
Dividend per share	$0.77	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	4.5%	Dividends paid / net income, when net income is positive.
Dividends / FCF	3.2%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	38.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$9.96B	Share price x shares outstanding.
Enterprise value	$10.02B	Market cap + total debt - cash - short-term investments.
P/E	18.7x	Market cap / net income. Only when net income is positive.
P/S	2.14x	Market cap / revenue.
P/B	3.35x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	20.8x	Market cap / tangible book value, when positive.
P/FCF	13.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	12.1x	Market cap / cash from operations, when positive.
EV/Sales	2.16x	Enterprise value / revenue.
EV/EBIT	14.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.5x	Enterprise value / EBITDA, when both are positive.
EV/FCF	13.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	7.5%	Free cash flow / market cap.
Earnings yield	5.3%	Net income / market cap (the inverse of P/E).
Dividend yield	0.2%	Dividends paid over the period / market cap.
Shareholder yield	3.1%	(Dividends paid + share buybacks) / market cap.
PEG	1.13x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was ACUITY INC. (DE)'s revenue in fiscal 2026?

ACUITY INC. (DE) reported revenue of $4.64B for fiscal 2026, 6.8% higher than the year before.

Was ACUITY INC. (DE) profitable in fiscal 2026?

Yes. Net income was $531.3M, a net margin of 11.4%.

How much free cash flow did ACUITY INC. (DE) generate in fiscal 2026?

Cash from operations of $825.6M minus capital expenditures of $77.7M left free cash flow of $747.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ACUITY INC. (DE)